Abattis Bioceuticals (Abattis Bioceuticals) Short-Term Capital Lease Obligation : $0.02 Mil (As of Sep. 2019)

View and export this data going back to . Start your Free Trial

What is Abattis Bioceuticals Short-Term Capital Lease Obligation?

Abattis Bioceuticals's Short-Term Capital Lease Obligation for the quarter that ended in Sep. 2019 was $0.02 Mil.

Abattis Bioceuticals's quarterly Short-Term Capital Lease Obligation stayed the same from Mar. 2019 ($0.00 Mil) to Jun. 2019 ($0.00 Mil) but then increased from Jun. 2019 ($0.00 Mil) to Sep. 2019 ($0.02 Mil).

Abattis Bioceuticals's annual Short-Term Capital Lease Obligation stayed the same from Sep. 2017 ($0.00 Mil) to Sep. 2018 ($0.00 Mil) but then increased from Sep. 2018 ($0.00 Mil) to Sep. 2019 ($0.02 Mil).

Abattis Bioceuticals Short-Term Capital Lease Obligation Historical Data

The historical data trend for Abattis Bioceuticals's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abattis Bioceuticals Short-Term Capital Lease Obligation Chart

Abattis Bioceuticals Annual Data

Trend

Sep10

Sep11

Sep12

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.02

Abattis Bioceuticals Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	-	-	-	0.02

Abattis Bioceuticals Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Abattis Bioceuticals Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Abattis Bioceuticals's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Abattis Bioceuticals (Abattis Bioceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abattis Bioceuticals Corp (OTCPK:ATTBF) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

1200 - 625 Howe Street, Vancouver, BC, CAN, V6C 2M6

Website

http://www.abattis.com

Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.